These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 2523644
1. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group. Am J Med; 1989 Apr 17; 86(4A):110-4. PubMed ID: 2523644 [Abstract] [Full Text] [Related]
2. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group. Am J Med; 1989 Apr 17; 86(4A):94-7. PubMed ID: 2523664 [Abstract] [Full Text] [Related]
3. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group. Am J Med; 1989 Apr 17; 86(4A):119-23. PubMed ID: 2523646 [Abstract] [Full Text] [Related]
4. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension. Sundstedt CD, Rüegg PC, Keller A, Waite R. Am J Med; 1989 Apr 17; 86(4A):98-102. PubMed ID: 2523665 [Abstract] [Full Text] [Related]
5. Additive effect of isradipine in combination with captopril in hypertensive patients. Eggertsen R, Svensson A, Dahlöf B, Hansson L. Am J Med; 1989 Apr 17; 86(4A):124-6. PubMed ID: 2523647 [Abstract] [Full Text] [Related]
6. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol. Frithz G, Aström B, Dahlöf B, Hansson L, Tollin C, Himanen P, Sundstedt CD. Am J Med; 1989 Apr 17; 86(4A):115-8. PubMed ID: 2523645 [Abstract] [Full Text] [Related]
7. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension. Simonsen K, Sundstedt CD. Am J Med; 1989 Apr 17; 86(4A):91-3. PubMed ID: 2523663 [Abstract] [Full Text] [Related]
8. Efficacy and safety of isradipine in hypertension. Shepherd AM, Carr AA, Davidov M, Hamilton J, Schnaper H, Velasquez M, Brockway B, Prisant LM, Hamilton B, Gonasun L. J Cardiovasc Pharmacol; 1989 Apr 17; 13(4):580-5. PubMed ID: 2470995 [Abstract] [Full Text] [Related]
9. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension. Winer N, Thys-Jacobs S, Kumar R, Davidson WD, Grayson M, Harris C, Walker D, Itskovitz H, Gonasun L. Clin Pharmacol Ther; 1987 Oct 17; 42(4):442-8. PubMed ID: 2959426 [Abstract] [Full Text] [Related]
13. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist. Nelson EB, Pool JL, Taylor AA. Clin Pharmacol Ther; 1986 Dec 17; 40(6):694-7. PubMed ID: 2946507 [Abstract] [Full Text] [Related]
15. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients. Holtzman JL, Abrams A, Cutler R, Hamilton B, Kirkendall WM, Neri G, Stein GH, Matthews KP. Clin Pharmacol Ther; 1990 Nov 17; 48(5):590-7. PubMed ID: 2146060 [Abstract] [Full Text] [Related]
19. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects. Rupoli L, Fruscio M, Gradnik R, Chianca R, Leonetti G, Zanchetti A. Am J Med; 1989 Apr 17; 86(4A):65-6. PubMed ID: 2523658 [Abstract] [Full Text] [Related]